Velpatasvir + Sofosbuvir Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: Sofosbuvir - 400 mg + Velpatasvir - 100 mg
Reference Brands: Epclusa(US & EU)
Category: Anti Viral
Velpatasvir + Sofosbuvir is available in Tablet and strengths such as Sofosbuvir - 400 mg + Velpatasvir - 100 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Velpatasvir + Sofosbuvir is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Velpatasvir + Sofosbuvir can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Epclusa is a once-daily, fixed-dose combination of Sofosbuvir 400 mg and Velpatasvir 100 mg, approved by the FDA and EMA for the treatment of chronic hepatitis C virus (HCV) infection across all six genotypes. This pan-genotypic regimen offers a high sustained virologic response (SVR) rate of over 95%, making it a preferred choice for both treatment-naïve and previously treated patients. Epclusa is suitable for use with or without ribavirin, depending on liver disease status. Its simplified, one-pill-daily format improves adherence and outcomes. It is also available for pediatric patients aged 3 years and older in tablet and granule forms.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Enfuvirtide Acetate
Strength:
90 mg/vial
Form: Injection
Reference Brands: Fuzeon (USA/EU)
View Details
Etravirine
Strength:
25 mg, 100 mg, 200 mg
Form: Tablets
Reference Brands: Intelence (USA), Intelence (EU)
View Details
Quick Response Guaranteed | Verified Suppliers
